INCY Incyte Corporation - Common Stock
$127.56
가격 · 8월 21, 2026
기준 재무 정보 7월 28, 2026
52주 범위
$81–$133
90% of range
애널리스트 평점
HOLD
33 analysts
목표 주가
$125
P/E (TTM)
19.9
ROE
27.6%
순이익률
25.0%
Incyte Corporation - Common Stock 정보 위키백과 회사 개요
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
더 보기
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity.
History
Incyte Corporation was founded by Roy A. Whitfield on April 8, 1991, in Palo Alto, California, as a genomics company. It became a public company in 1993. Subsequently, scientists and chemists were recruited from DuPont to work for Incyte. Incyte moved its headquarters to Delaware, and acquired Maxia Pharmaceuticals in 2003.
In November 2013, Incyte announced its relocation to new headquarters in Wilmington, Delaware, completing the move by the end of 2014. Hervé Hoppenot became CEO in January 2014.
In 2017, the company became part of the S&P 500 Index, which tracks the 500 most widely held U.S. stocks.
In 2015, Incyte established its European headquarters in Geneva, Switzerland, and later moved this headquarters in 2021. The company expanded its Delaware headquarters, including the addition of a research and development facility, in 2022. Incyte acquired Villaris Therapeutics in 2022, and Escient Pharmaceuticals in 2024.
For 2025, the company reported $5.141 billion in revenue, $6.957 billion in assets and $1.286 billion in net income. Incyte is publicly traded on the NASDAQ under the symbol INCY. Incyte now operates out of North America, Asia, and Europe. Bill Meury became CEO in 2025. Meury replaced Hoppenot, who retired after 11 years in the position.
Pharmaceuticals
Incyte Corporation currently has seven marketed and co-marketed pharmaceutical products, including Jakafi (ruxolitinib), Pemazyre (pemigatinib), Monjuvi (tafasitamab-cxix), Opzelura (Ruxolitinib), Tabrecta (capmatinib), Olumiant (Baricitinib), and Iclusig (ponatinib).
In 2013, Novartis acquired Incyte's c-Met inhibitor capmatinib (INC280, INCB028060), which is marketed under the brand name Tabrecta.
As of 2014, the company was developing baricitinib, an oral JAK1 and JAK2 inhibitor drug for rheumatoid arthritis in partnership with Eli Lilly. It gained EU approval in February 2017. In April 2017, the US FDA issued a rejection, citing concerns about dosing and safety. In May 2018, baricitinib was approved in the United States for the treatment of rheumatoid arthritis under the brand name Olumiant.
As of 2016 epacadostat, an indoleamine 2,3-dioxygenase (IDO1) inhibitor, was in development for various cancers and was in combination trials with Merck's pembrolizumab (Keytruda) and Bristol Myers Squibb's nivolumab (Opdivo).
Acquisition history
Incyte has made a total of 3 acquisitions.
Maxia Pharmaceuticals (2003): An early acquisition in Incyte's history, the company purchased Maxia in 2003 for $42 million.
Villaris Therapeutics (2022): This acquisition was valued at approximately $1.4 billion and included an upfront payment along with milestones. It added new assets to Incyte's portfolio for treating vitiligo and other autoimmune conditions.
Escient Pharmaceuticals (2024): In May 2024, Incyte acquired this San Diego-based, clinical-stage company for $750 million. The acquisition provided Incyte with two oral drug candidates for inflammatory diseases, EP262 and EP547.
출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗
INCY 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$127.56
시가총액
$25.31B
P/E (TTM)
19.9
EPS (TTM)
$6.41
매출 (TTM)
$5.14B
배당 수익률
—
ROE
27.6%
부채/자본
—
52주 범위
$81 – $133
INCY 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
$5.14B
2016-12-31
→
2025-12-31
EPS
$6.41
2016-12-31
→
2025-12-31
잉여현금흐름
—
2017-12-31
→
2022-12-31
마진
25.0%
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
INCY
동종업계 중앙값
P/E (TTM)
19.9
17.7
P/S (TTM)
4.9
6.8
P/B
4.9
6.4
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
INCY
동종업계 중앙값
Operating Margin (영업이익률)
29.5%
—
Net Profit Margin (순이익률)
25.0%
20.3%
ROA
20.8%
11.4%
ROE
27.6%
16.8%
ROIC
22.7%
—
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
INCY
동종업계 중앙값
Current Ratio (유동비율)
3.3
3.4
Quick Ratio (당좌 비율)
2.0
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
INCY
동종업계 중앙값
Revenue YoY (매출 YoY)
21.2%
—
Revenue CAGR 3Y (매출 CAGR 3년)
14.8%
—
Revenue CAGR 5Y (매출 CAGR 5년)
14.0%
—
EPS YoY
4173.3%
—
Net Income YoY (순이익 YoY)
3845.0%
—
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
INCY
동종업계 중앙값
INCY 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
33 명의 애널리스트
- 적극 매수 8 24.2%
- 매수 9 27.3%
- 보유 16 48.5%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
23 명의 애널리스트 · 2026-08-18
중앙값
$120.00
지금
$127.56
저가
$86.00
고가
$155.00
중앙값 목표
$120.00
-5.9%
평균 목표
$125.17
-1.9%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
0.33%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $3.09 | $2.14 | 0.95% |
| 2026년 3월 31일 | $1.81 | $1.40 | 0.41% |
| 2025년 12월 31일 | $1.80 | $1.97 | -0.17% |
| 2025년 9월 30일 | $2.26 | $1.69 | 0.57% |
| 2025년 6월 30일 | $1.57 | $1.50 | 0.07% |
| 2025년 3월 31일 | $1.16 | $1.04 | 0.12% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| INCY | $19.60B | 15.4 | 21.2% | 25.0% | 27.6% | — |
| NTRA | $32.00B | -150.7 | 35.9% | -9.0% | -14.1% | — |
| RVMD | — | — | — | — | — | — |
| BIIB | $25.84B | 20.0 | 2.2% | 13.1% | 7.2% | — |
| ALNY | $52.64B | 170.7 | 65.2% | 8.5% | 60.4% | — |
| INSM | $37.29B | -27.1 | 66.7% | -210.5% | -128.4% | — |
| UTHR | $21.27B | 17.5 | 10.6% | 41.9% | 18.7% | 87.9% |
| BBIO | $14.90B | -20.2 | 126.3% | -146.0% | 41.2% | — |
| NBIX | $14.20B | 30.4 | 21.4% | 16.7% | 16.1% | — |
| EXEL | $11.44B | 15.7 | 7.0% | 33.7% | 37.3% | — |
| BMRN | $11.43B | 33.0 | 12.9% | 10.8% | 5.8% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 17
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.14B | $4.24B | $3.70B | $3.39B | $2.99B | $2.67B | $2.16B | $1.88B | $1.54B | $1.11B | $754M | $511M | |
| Cost of Revenue | $372M | $312M | $255M | $207M | $151M | $131M | $114M | $94M | $79M | $58M | $27M | $3M | |
| R&D Expense | $2.05B | $2.61B | $1.63B | $1.59B | $1.46B | $2.22B | $1.15B | $1.20B | $1.33B | $582M | $480M | $348M | |
| SG&A Expense | $1.38B | $1.24B | $1.16B | $1.00B | $740M | $517M | $469M | $434M | $366M | $303M | $197M | $166M | |
| Operating Expenses | $3.63B | $4.18B | $3.08B | $2.82B | $2.40B | $2.93B | $1.76B | $1.75B | $1.78B | $961M | $703M | $516M | |
| Operating Income | $1.51B | $61M | $621M | $579M | $586M | $-264M | $402M | $129M | $-243M | $145M | $51M | $-5M | |
| Interest Expense | · | · | $3M | $3M | $2M | $2M | $2M | $2M | $7M | $39M | $46M | $47M | |
| Interest Income | $106M | $129M | $158M | $40M | · | · | · | · | · | · | · | · | |
| Other Non-op | $25M | $13M | $14M | $-519.0K | $11M | $23M | $52M | $32M | $17M | · | · | · | |
| Pretax Income | $1.66B | $317M | $834M | $529M | $570M | $-232M | $487M | $115M | $-312M | $107M | $8M | $-49M | |
| Income Tax | $378M | $284M | $237M | $188M | $-378M | $63M | $40M | $6M | $852.0K | $3M | $1M | $-66.0K | |
| Net Income | $1.29B | $33M | $598M | $341M | $949M | $-296M | $447M | $109M | $-313M | $104M | · | · | |
| EPS (Basic) | $6.59 | $0.16 | $2.67 | $1.53 | $4.30 | $-1.36 | $2.08 | $0.52 | $-1.53 | $0.55 | $0.04 | $-0.29 | |
| EPS (Diluted) | $6.41 | $0.15 | $2.65 | $1.52 | $4.27 | $-1.36 | $2.05 | $0.51 | $-1.53 | $0.54 | $0.03 | $-0.29 | |
| Shares (Basic) | 195,204,000 | 207,110,000 | 223,628,000 | 222,004,000 | 220,428,000 | 218,073,000 | 214,913,000 | 212,383,000 | 204,580,000 | 187,873,000 | 179,601,000 | 167,947,000 | |
| Shares (Diluted) | 200,700,000 | 210,530,000 | 225,928,000 | 223,958,000 | 222,074,000 | 218,073,000 | 217,657,000 | 215,635,000 | 204,580,000 | 194,125,000 | 187,302,000 | 167,947,000 | |
| EBITDA | $1.61B | $151M | · | $647M | $644M | $-212M | $457M | $184M | $-192M | · | · | $37M |
대차대조표 27
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.10B | $1.69B | $3.21B | $2.95B | $2.06B | $1.51B | $1.83B | $1.16B | $900M | $652M | $521M | $452M | |
| Short-term Investments | · | · | · | · | · | · | $285M | $274M | $270M | $156M | $186M | $148M | |
| Inventory | $101M | $59M | $63M | $42M | $28M | $16M | $11M | $7M | $6M | $4M | $2M | $358.0K | |
| Prepaid Expense | $318M | $169M | $183M | $167M | $126M | $60M | $44M | $79M | $62M | $33M | $18M | $21M | |
| Current Assets | $5.02B | $3.24B | $4.65B | $4.09B | $3.12B | $2.36B | $2.48B | $1.83B | $1.50B | $994M | $842M | $680M | |
| PP&E (Net) | $731M | $763M | $752M | $739M | $724M | $560M | $378M | $320M | $260M | $168M | $86M | $82M | |
| PP&E (Gross) | $1.11B | $1.09B | $1.02B | $952M | $900M | $704M | $499M | $423M | $334M | $219M | $131M | $116M | |
| Accum. Depreciation | $375M | $328M | $270M | $213M | $176M | $144M | $122M | $103M | $75M | $52M | $45M | $35M | |
| Goodwill | $133M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | · | · | |
| Intangibles | · | · | · | · | · | · | · | · | $237M | $270M | $12M | $2M | |
| Other Non-current Assets | $18M | $11M | $52M | $25M | $37M | $39M | $49M | $19M | $2M | $3M | $12M | · | |
| Total Assets | $6.96B | $5.44B | $6.78B | $5.84B | $4.93B | $3.56B | $3.43B | $2.65B | $2.30B | $1.64B | $1.01B | $796M | |
| Accounts Payable | $210M | $197M | $110M | $278M | $172M | $99M | $84M | $104M | $68M | $76M | $30M | $24M | |
| Accrued Liabilities | $1.03B | $1.21B | $936M | $701M | $534M | $378M | $286M | $229M | $199M | $127M | $87M | $62M | |
| Current Liabilities | $1.52B | $1.64B | $1.24B | $1.16B | $854M | $631M | $513M | $425M | $375M | $274M | $168M | $221M | |
| Capital Leases | $15M | $17M | $14M | $14M | $16M | $14M | $12M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $20M | |
| Other Non-current Liabilities | $165M | $168M | $149M | $99M | $70M | $58M | $40M | $22M | $20M | $13M | $48M | $55M | |
| Total Liabilities | $1.79B | $2.00B | $1.59B | $1.47B | $1.16B | $950M | $828M | $720M | $672M | $1.22B | $836M | $878M | |
| Long-term Debt | · | · | · | · | · | · | · | $19.09B | $27M | $750M | $750M | $841M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $689M | |
| Common Stock | $198.0K | $193.0K | $224.0K | $223.0K | $221.0K | $219.0K | $216.0K | $213.0K | $211.0K | $189.0K | $187.0K | $171.0K | |
| Retained Earnings | $214M | $-1.07B | $160M | $-437M | $-778M | $-1.73B | $-1.43B | $-1.88B | $-1.99B | $-1.67B | $-1.78B | $-1.79B | |
| AOCI | $25M | $-13M | $13M | $15M | $-19M | $-15M | $-16M | $-10M | $-7M | $-3M | $-809.0K | $2M | |
| Stockholders' Equity | $5.17B | $3.45B | $5.19B | $4.37B | $3.77B | $2.61B | $2.60B | $1.93B | $1.63B | $419M | $171M | $-82M | |
| Liabilities + Equity | $6.96B | $5.44B | $6.78B | $5.84B | $4.93B | $3.56B | $3.43B | $2.65B | $2.30B | $1.64B | $1.01B | $796M | |
| Shares Outstanding | 198,460,009 | 193,434,305 | 224,286,862 | 222,746,719 | 221,084,433 | 219,489,329 | 216,177,830 | 213,274,660 | 211,262,906 | 188,848,752 | 186,650,249 | 170,876,619 |
현금 흐름 16
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $93M | $89M | $83M | $68M | $58M | $52M | $55M | $55M | $52M | $58M | $45M | $41M | |
| Stock-based Comp | $249M | $266M | $216M | $188M | $183M | $178M | $167M | $148M | $133M | $96M | $70M | $62M | |
| Deferred Tax | $248M | $-86M | $-159M | $57M | $-466M | $-350.0K | $-377.0K | $-459.0K | $-805.0K | · | · | · | |
| Amort. of Intangibles | $27M | $24M | $22M | $22M | $22M | $22M | $22M | $22M | $22M | $13M | · | · | |
| Other Non-cash | $-463M | $33M | · | $316M | $26M | $-58M | $43M | $24M | · | · | · | · | |
| Operating Cash Flow | $1.41B | $335M | $496M | $970M | $749M | $-125M | $711M | $336M | $-93M | $305M | $89M | $26M | |
| CapEx | · | · | · | $78M | $181M | $187M | $78M | $73M | $111M | $120M | $26M | $28M | |
| Investing Cash Flow | $-103M | $158M | $-208M | $-79M | $-208M | $-269M | $-87M | $-86M | $-350M | $-232M | $-105M | · | |
| Stock Issued | · | · | · | · | · | · | · | · | $649M | · | · | · | |
| Stock Repurchased | $0 | $2.00B | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $0 | $-2.00B | · | · | · | · | · | · | $649M | · | · | · | |
| Financing Cash Flow | $101M | $-2.02B | $-20M | $-794.0K | $6M | $72M | $46M | $15M | $690M | $45M | $85M | · | |
| Net Change in Cash | $1.41B | $-1.53B | $262M | $894M | $544M | $-319M | $669M | $265M | $247M | $117M | $69M | $-19M | |
| Taxes Paid | $212M | $373M | $378M | $136M | $68M | $71M | $34M | $5M | $6M | $927.0K | · | · | |
| Free Cash Flow | · | · | · | $892M | $568M | $-312M | $633M | $263M | $-204M | · | · | $-2M | |
| Levered FCF | · | · | · | $890M | $565M | $-315M | $631M | $261M | $-211M | · | · | $-48M |
수익성 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 29.5% | 1.5% | · | 17.1% | 19.6% | -9.9% | 18.6% | 6.9% | -15.9% | · | · | -0.94% | |
| Net Margin | 25.0% | 0.77% | · | 10.0% | 31.8% | -11.1% | 20.7% | 5.8% | · | · | · | · | |
| Pretax Margin | 32.4% | 7.5% | · | 15.6% | 19.1% | -8.7% | 22.6% | 6.1% | -20.3% | · | · | -9.5% | |
| EBITDA Margin | 31.3% | 3.5% | · | 19.1% | 21.6% | -7.9% | 21.1% | 9.8% | -12.5% | · | · | 7.2% | |
| ROA | 20.8% | 0.53% | · | 6.3% | 22.3% | -8.5% | 14.7% | 4.4% | · | · | · | · | |
| ROE | 27.6% | 0.99% | · | 7.9% | 27.4% | -11.8% | 17.8% | 5.9% | · | · | · | · | |
| ROIC | 22.7% | 0.18% | · | 8.5% | 25.8% | -12.9% | 14.2% | 6.4% | -15.0% | · | · | -0.79% |
유동성 및 지급능력 4
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | 2.0 | · | 3.5 | 3.7 | 3.7 | 4.8 | 4.3 | 4.0 | · | · | 3.2 | |
| Quick Ratio | 2.0 | 1.0 | · | 2.6 | 2.4 | 2.4 | 4.1 | 3.4 | 3.1 | · | · | 2.7 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | -8.4 | |
| Interest Coverage | · | · | · | 217.3 | 307.0 | -121.3 | 216.7 | 83.7 | -35.3 | · | · | -0.1 |
효율성 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | · | 0.6 | 0.7 | 0.8 | 0.7 | 0.8 | 0.8 | · | · | 0.7 | |
| Inventory Turnover | 4.7 | 5.1 | · | 5.9 | 6.8 | 9.4 | 12.4 | 14.0 | 15.0 | · | · | 7.9 |
성장률 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 21.2% | 14.8% | 8.9% | 13.7% | 12.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 14.8% | 12.4% | 11.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 14.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 4173.3% | -94.3% | 74.3% | -64.4% | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 61.6% | -67.2% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 3845.0% | -94.5% | 75.4% | -64.1% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 55.7% | -67.5% | · | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM) 10
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.14B | $4.24B | $3.70B | $3.39B | $2.99B | $2.67B | $2.16B | $1.88B | $1.54B | $1.11B | $754M | $511M | |
| Net Income TTM | $1.29B | $33M | $598M | $341M | $949M | $-296M | $447M | $109M | $-313M | $104M | · | · | |
| Market Cap | $19.60B | $13.36B | · | $17.89B | $16.23B | $19.09B | $18.88B | $13.56B | $20.01B | · | · | · | |
| P/E | 15.4 | 460.5 | 23.7 | 52.8 | 17.2 | -64.0 | 42.6 | 124.7 | -61.9 | 185.7 | 3615.0 | -252.1 | |
| P/S | 3.8 | 3.2 | · | 5.3 | 5.4 | 7.2 | 8.7 | 7.2 | 13.0 | · | · | · | |
| P/B | 3.8 | 3.9 | · | 4.1 | 4.3 | 7.3 | 7.3 | 7.0 | 12.3 | · | · | · | |
| P / Tangible Book | 3.9 | 4.1 | 2.8 | 4.2 | 4.5 | 7.8 | · | · | · | · | · | · | |
| P / Cash Flow | 13.9 | 39.8 | · | 18.4 | 21.7 | -153.2 | 26.6 | 40.3 | -215.2 | · | · | · | |
| P / FCF | · | · | · | 20.1 | 28.5 | -61.2 | 29.8 | 51.6 | -98.1 | · | · | · | |
| Earnings Yield | 6.5% | 0.22% | 4.2% | 1.9% | 5.8% | -1.6% | 2.4% | 0.80% | -1.6% | 0.54% | 0.03% | -0.40% |
손익계산서 17
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.67B | $1.27B | $1.51B | $1.37B | $1.22B | $1.05B | $1.18B | $1.14B | $1.04B | $881M | $1.01B | $919M | $955M | $809M | $927M | $823M | |
| Cost of Revenue | $105M | $105M | $121M | $99M | $79M | $73M | $88M | $86M | $77M | $61M | $70M | $60M | $68M | $57M | $59M | $55M | |
| R&D Expense | $517M | $516M | $611M | $507M | $495M | $437M | $466M | $573M | $1.14B | $429M | $444M | $376M | $401M | $407M | $501M | $384M | |
| SG&A Expense | $352M | $328M | $390M | $329M | $331M | $326M | $327M | $309M | $306M | $300M | $288M | $268M | $284M | $316M | $273M | $266M | |
| Operating Expenses | $976M | $972M | $1.17B | $922M | $685M | $848M | $877M | $992M | $1.52B | $789M | $826M | $704M | $761M | $784M | $857M | $685M | |
| Operating Income | $698M | $301M | $336M | $444M | $530M | $205M | $302M | $146M | $-478M | $92M | $187M | $215M | $194M | $25M | $70M | $138M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $430.0K | · | $623.0K | $655.0K | $469.0K | · | $641.0K | |
| Interest Income | $38M | $34M | $31M | $27M | $25M | $23M | $21M | $19M | $41M | $47M | · | · | · | · | · | · | |
| Other Non-op | $6M | $3M | $6M | $4M | $7M | $8M | $2M | $5M | $8M | $-2M | $-108M | $46M | $43M | $33M | $-14M | $12M | |
| Pretax Income | $752M | $344M | $390M | $482M | $558M | $234M | $314M | $157M | $-390M | $236M | $271M | $234M | $278M | $52M | $81M | $149M | |
| Income Tax | $166M | $40M | $91M | $58M | $153M | $76M | $113M | $50M | $55M | $67M | $70M | $63M | $74M | $30M | $52M | $36M | |
| Net Income | $586M | $303M | $299M | $424M | $405M | $158M | $201M | $106M | $-445M | $170M | $201M | $171M | $204M | $22M | $28M | $113M | |
| EPS (Basic) | $2.92 | $1.52 | $1.51 | $2.17 | $2.09 | $0.82 | $0.89 | $0.55 | $-2.04 | $0.76 | $0.90 | $0.76 | $0.91 | $0.10 | $0.12 | $0.51 | |
| EPS (Diluted) | $2.81 | $1.47 | $1.46 | $2.11 | $2.04 | $0.80 | $0.90 | $0.54 | $-2.04 | $0.75 | $0.89 | $0.76 | $0.90 | $0.10 | $0.13 | $0.50 | |
| Shares (Basic) | 200,378,000 | 199,343,000 | -388,173,000 | 195,670,000 | 193,995,000 | 193,712,000 | -428,178,000 | 192,629,000 | 218,175,000 | 224,484,000 | -446,658,000 | 224,078,000 | 223,248,000 | 222,960,000 | -443,397,000 | 222,415,000 | |
| Shares (Diluted) | 208,216,000 | 206,830,000 | -397,670,000 | 201,429,000 | 198,744,000 | 198,197,000 | -430,702,000 | 195,838,000 | 218,175,000 | 227,219,000 | -451,477,000 | 226,167,000 | 225,649,000 | 225,589,000 | -446,828,000 | 224,175,000 | |
| EBITDA | $698M | $325M | · | $444M | $530M | $228M | · | $146M | $-478M | $114M | · | $215M | $194M | $44M | · | $138M |
대차대조표 22
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.98B | $3.46B | $3.10B | $2.46B | $1.95B | $1.94B | $1.69B | $1.30B | $987M | $3.35B | · | $3.23B | $3.13B | $2.82B | · | $2.69B | |
| Inventory | $113M | $116M | $101M | $83M | $83M | $64M | $59M | $70M | $101M | $64M | · | $57M | $36M | $41M | · | $46M | |
| Prepaid Expense | $253M | $301M | $318M | $369M | $296M | $212M | $169M | $205M | $208M | $189M | · | $172M | $167M | $194M | · | $180M | |
| Current Assets | $6.03B | $5.48B | $5.02B | $4.28B | $3.64B | $3.51B | $3.24B | $2.81B | $2.57B | $4.85B | · | $4.40B | $4.26B | $3.97B | · | $3.82B | |
| PP&E (Net) | $709M | $720M | $731M | $799M | $799M | $765M | $763M | $773M | $762M | $720M | · | $733M | $749M | $742M | · | $716M | |
| PP&E (Gross) | $1.11B | $1.11B | $1.11B | $1.16B | $1.14B | $1.11B | $1.09B | $1.09B | $1.06B | $1.00B | · | $986M | $988M | $967M | · | $918M | |
| Accum. Depreciation | $404M | $389M | $375M | $361M | $346M | $344M | $328M | $316M | $298M | $283M | · | $253M | $239M | $226M | · | $202M | |
| Goodwill | $133M | $133M | $133M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | · | $156M | $156M | $156M | · | $156M | |
| Other Non-current Assets | $87M | $24M | $18M | $32M | $33M | $30M | $11M | $40M | $22M | $47M | · | $81M | $32M | $21M | · | $24M | |
| Total Assets | $7.87B | $7.34B | $6.96B | $6.33B | $5.82B | $5.75B | $5.44B | $5.01B | $4.66B | $7.14B | · | $6.39B | $6.21B | $5.80B | · | $5.51B | |
| Accounts Payable | $250M | $229M | $210M | $172M | $241M | $196M | $197M | $179M | $148M | $164M | · | $139M | $156M | $56M | · | $163M | |
| Accrued Liabilities | $870M | $1.09B | $1.03B | $948M | $857M | $1.38B | $1.21B | $1.13B | $1.03B | $1.10B | · | $821M | $811M | $825M | · | $700M | |
| Current Liabilities | $1.31B | $1.49B | $1.52B | $1.34B | $1.28B | $1.72B | $1.64B | $1.50B | $1.34B | $1.40B | · | $1.12B | $1.12B | $1.01B | · | $1.01B | |
| Capital Leases | · | · | $15M | · | · | · | $17M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $125M | $127M | $165M | $171M | $180M | $176M | $168M | $145M | $142M | $151M | · | $133M | $140M | $118M | · | $75M | |
| Total Liabilities | $1.53B | $1.72B | $1.79B | $1.68B | $1.65B | $2.08B | $2.00B | $1.84B | $1.66B | $1.74B | · | $1.46B | $1.47B | $1.34B | · | $1.28B | |
| Common Stock | $201.0K | $200.0K | $198.0K | $196.0K | $194.0K | $193.0K | $193.0K | $192.0K | $191.0K | $224.0K | · | $224.0K | $223.0K | $223.0K | · | $222.0K | |
| Retained Earnings | $1.10B | $517M | $214M | $-86M | $-510M | $-915M | $-1.07B | $-1.27B | $-1.38B | $330M | · | $-41M | $-212M | $-416M | · | $-466M | |
| AOCI | $20M | $22M | $25M | $15M | $13M | $-6M | $-13M | $16M | $-5M | $-6M | · | $23M | $27M | $21M | · | $-29M | |
| Stockholders' Equity | $6.34B | $5.62B | $5.17B | $4.65B | $4.17B | $3.67B | $3.45B | $3.17B | $3.00B | $5.39B | $5.19B | $4.93B | $4.74B | $4.46B | $4.37B | $4.23B | |
| Liabilities + Equity | $7.87B | $7.34B | $6.96B | $6.33B | $5.82B | $5.75B | $5.44B | $5.01B | $4.66B | $7.14B | · | $6.39B | $6.21B | $5.80B | · | $5.51B | |
| Shares Outstanding | 200,977,687 | 199,948,401 | 198,460,009 | 196,130,993 | 194,123,265 | 193,783,446 | 193,434,305 | 192,798,328 | 191,572,449 | 224,533,449 | · | 224,101,839 | 223,338,330 | 223,061,787 | · | 222,454,839 |
현금 흐름 10
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $26M | $24M | $24M | $24M | $23M | $22M | $23M | $23M | $22M | $22M | $22M | $21M | $20M | $19M | $18M | $17M | |
| Stock-based Comp | $67M | $64M | $62M | $62M | $65M | $61M | $72M | $78M | $57M | $60M | $60M | $48M | $55M | $53M | $53M | $45M | |
| Other Non-cash | · | $-22M | · | · | · | $25M | · | · | · | $-32M | · | · | · | $-200M | · | · | |
| Operating Cash Flow | $508M | $369M | $543M | $559M | $45M | $266M | $381M | $311M | $-576M | $219M | $148M | $148M | $307M | $-106M | $284M | $296M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $28M | |
| Investing Cash Flow | $-52M | $-88M | $-37M | $-47M | $-19M | $1M | $-21M | $38M | $214M | $-73M | $-154M | $-17M | $-7M | $-29M | $-21M | $-28M | |
| Stock Repurchased | · | · | $0 | $0 | · | · | $0 | $103.0K | · | · | $0 | $0 | · | · | · | · | |
| Financing Cash Flow | $65M | $85M | $138M | $-13M | $-11M | $-13M | $20M | $-32M | $-2.00B | $-12M | $346.0K | $-37M | $13M | $4M | $-2M | $-14M | |
| Net Change in Cash | $521M | $363M | $643M | $500M | $13M | $254M | $384M | $317M | $-2.36B | $133M | $-14M | $96M | $310M | $-130M | $261M | $255M | |
| Taxes Paid | $15M | $-9M | $27M | $7M | $177M | $844.0K | $70M | $73M | $227M | $3M | $125M | $116M | $130M | $7M | $20M | $40M |
수익성 7
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 41.7% | 23.7% | · | 32.5% | 43.6% | 19.5% | · | 12.8% | -45.8% | 10.4% | · | 23.4% | 20.3% | 3.1% | · | 16.8% | |
| Net Margin | 35.0% | 23.8% | · | 31.1% | 33.3% | 15.0% | · | 9.4% | -42.6% | 19.2% | · | 18.6% | 21.3% | 2.7% | · | 13.7% | |
| Pretax Margin | 44.9% | 27.0% | · | 35.3% | 45.9% | 22.2% | · | 13.8% | -37.3% | 26.8% | · | 25.4% | 29.1% | 6.4% | · | 18.1% | |
| EBITDA Margin | 41.7% | 25.5% | · | 32.5% | 43.6% | 21.6% | · | 12.8% | -45.8% | 12.9% | · | 23.4% | 20.3% | 5.4% | · | 16.8% | |
| ROA | 8.6% | 4.6% | · | 7.5% | 7.7% | 2.5% | · | 1.9% | -8.2% | 2.6% | · | 2.9% | 3.5% | 0.40% | · | 2.3% | |
| ROE | 11.1% | 6.5% | · | 10.8% | 11.3% | 3.5% | · | 2.6% | -11.5% | 3.4% | · | 3.7% | 4.6% | 0.52% | · | 3.1% | |
| ROIC | 8.6% | 4.7% | · | 8.4% | 9.2% | 3.8% | · | 3.1% | -18.2% | 1.2% | · | 3.2% | 3.0% | 0.23% | · | 2.5% |
유동성 및 지급능력 3
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 3.7 | · | 3.2 | 2.8 | 2.0 | · | 1.9 | 1.9 | 3.5 | · | 3.9 | 3.8 | 3.9 | · | 3.8 | |
| Quick Ratio | 3.0 | 2.3 | · | 1.8 | 1.5 | 1.1 | · | 0.9 | 0.7 | 2.4 | · | 2.9 | 2.8 | 2.8 | · | 2.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 213.7 | · | 344.6 | 295.8 | 52.8 | · | 215.9 |
효율성 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | |
| Inventory Turnover | 1.1 | 1.2 | · | 1.3 | 0.9 | 1.1 | · | 1.3 | 1.1 | 1.2 | · | 1.2 | 1.5 | 1.5 | · | 1.6 |
가치 평가 (TTM) 9
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.53B | $4.91B | · | $4.77B | $4.45B | $4.12B | · | $3.98B | $3.80B | $3.56B | · | $3.51B | $3.50B | $3.28B | · | $3.28B | |
| Net Income TTM | $1.72B | $1.29B | · | $1.09B | $225M | $-10M | · | $3M | $100M | $566M | · | $509M | $499M | $334M | · | $494M | |
| Market Cap | $22.78B | $18.82B | · | $16.63B | $13.22B | $11.73B | · | $12.74B | $11.61B | $12.79B | · | $12.95B | $13.90B | $16.12B | · | $14.82B | |
| P/E | 13.4 | 14.7 | · | 15.4 | 50.8 | 1211.0 | · | 6610.0 | 163.8 | 22.7 | · | 25.6 | 28.0 | 48.5 | · | 30.2 | |
| P/S | 4.1 | 3.8 | · | 3.5 | 3.0 | 2.9 | · | 3.2 | 3.1 | 3.6 | · | 3.7 | 4.0 | 4.9 | · | 4.5 | |
| P/B | 3.6 | 3.3 | · | 3.6 | 3.2 | 3.2 | · | 4.0 | 3.9 | 2.4 | · | 2.6 | 2.9 | 3.6 | · | 3.5 | |
| P / Tangible Book | 3.7 | 3.4 | · | 3.7 | 3.3 | 3.3 | · | 4.2 | 4.1 | 2.4 | · | 2.7 | 3.0 | 3.7 | · | 3.6 | |
| P / Cash Flow | · | 51.0 | · | · | · | 44.1 | · | · | · | 58.5 | · | · | · | -152.7 | · | · | |
| Earnings Yield | 7.4% | 6.8% | · | 6.5% | 2.0% | 0.08% | · | 0.02% | 0.61% | 4.4% | · | 3.9% | 3.6% | 2.1% | · | 3.3% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $5.14B | $4.24B | $3.70B | $3.39B | $2.99B |
| 영업이익률 % | 29.5% | 1.5% | — | 17.1% | 19.6% |
| 순이익 | $1.29B | $33M | $598M | $341M | $949M |
| 희석 EPS | $6.41 | $0.15 | $2.65 | $1.52 | $4.27 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 유동비율 | 3.3 | 2.0 | — | 3.5 | 3.7 |
| 당좌 비율 | 2.0 | 1.0 | — | 2.6 | 2.4 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | — | — | — | $892M | $568M |
최신 뉴스 이 회사 관련 최근 헤드라인
트레이딩 시그널 진입 가격 및 위험/보상 비율을 포함한 최근 매수/매도 신호
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 928개의 제출자 · $16.2B 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 123 (-1 이전 분기 대비) | 67 (-29 이전 분기 대비) | 352 (+38 이전 분기 대비) | 263 (-21 이전 분기 대비) | -2.3M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $3,487,217,729 | 30,762,330 | 21.55% | 주식 |
| Dodge & Cox | $1,355,482,475 | 11,957,326 | 8.38% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $1,249,713,401 | 11,024,289 | 7.72% | 주식 |
| STATE STREET CORP | $1,102,124,009 | 9,722,336 | 6.81% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $883,198,076 | 7,791,091 | 5.46% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $472,254,570 | 4,183,857 | 2.92% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $398,135,284 | 3,512,132 | 2.46% | 주식 |
| WELLINGTON MANAGEMENT GROUP LLP | $384,786,803 | 3,394,379 | 2.38% | 주식 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $311,168,439 | 2,744,958 | 1.92% | 주식 |
| Robeco Institutional Asset Management B.V. | $276,795,075 | 2,441,735 | 1.71% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $227,123,448 | 2,003,559 | 1.40% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $201,199,603 | 1,774,874 | 1.24% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $191,845,249 | 1,692,354 | 1.19% | 주식 |
| FIRST TRUST ADVISORS LP | $180,015,041 | 1,587,996 | 1.11% | 주식 |
| VICTORY CAPITAL MANAGEMENT INC | $167,811,569 | 1,480,342 | 1.04% | 주식 |
| Caisse de depot et placement du Quebec | $155,360,220 | 1,370,503 | 0.96% | 주식 |
| AustralianSuper Pty Ltd | $135,634,220 | 1,196,491 | 0.84% | 주식 |
| NORGES BANK | $126,861,970 | 1,119,107 | 0.78% | 주식 |
| FMR LLC | $116,316,542 | 1,026,081 | 0.72% | 주식 |
| ROYAL BANK OF CANADA | $115,263,000 | 1,016,790 | 0.71% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $106,959,694 | 943,540 | 0.66% | 주식 |
| ARMISTICE CAPITAL, LLC | $102,024,567 | 900,005 | 0.63% | 주식 |
| PANAGORA ASSET MANAGEMENT INC | $99,970,937 | 881,889 | 0.62% | 주식 |
| GOLDMAN SACHS GROUP INC | $97,568,045 | 860,692 | 0.60% | 주식 |
| VANGUARD GROUP INC | $91,396,622 | 925,348 | 0.56% | 주식 |
| Sound Shore Management Inc /CT/ | $85,895,479 | 757,723 | 0.53% | 주식 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $82,953,901 | 731,774 | 0.51% | 주식 |
| Gotham Asset Management, LLC | $81,567,621 | 719,545 | 0.50% | 주식 |
| Pictet Asset Management Holding SA | $81,315,880 | 713,354 | 0.50% | 주식 |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $75,887,460 | 768,325 | 0.47% | 주식 |
| MACKENZIE FINANCIAL CORP | $71,967,956 | 634,862 | 0.44% | 주식 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $65,633,852 | 578,986 | 0.41% | 주식 |
| Legal & General Group Plc | $63,331,398 | 558,675 | 0.39% | 주식 |
| SEB Asset Management AB | $63,307,742 | 558,467 | 0.39% | 주식 |
| GLENMEDE TRUST CO NA | $60,308,653 | 532,010 | 0.37% | 주식 |
| Woodline Partners LP | $58,118,538 | 512,690 | 0.36% | 주식 |
| MARSHALL WACE, LLP | $56,804,130 | 501,095 | 0.35% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $56,779,870 | 500,881 | 0.35% | 주식 |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $55,184,782 | 486,810 | 0.34% | 주식 |
| BlackRock, Inc. | $54,675,002 | 482,313 | 0.34% | 주식 |
| Swiss National Bank | $54,058,437 | 476,874 | 0.33% | 주식 |
| Glenmede Investment Management, LP | $53,145,338 | 626,640 | 0.33% | 주식 |
| Vinva Investment Management Ltd | $53,069,578 | 462,843 | 0.33% | 주식 |
| CANADA PENSION PLAN INVESTMENT BOARD | $50,161,800 | 442,500 | 0.31% | 주식 |
| California Public Employees Retirement System | $48,730,290 | 429,872 | 0.30% | 주식 |
| RHUMBLINE ADVISERS | $48,578,406 | 428,533 | 0.30% | 주식 |
| IEQ CAPITAL, LLC | $48,141,997 | 424,682 | 0.30% | 주식 |
| Mitsubishi UFJ Asset Management Co., Ltd. | $46,733,567 | 412,258 | 0.29% | 주식 |
| Sumitomo Mitsui Trust Group, Inc. | $44,634,140 | 393,738 | 0.28% | 주식 |
| Vanguard Global Advisers, LLC | $43,080,994 | 380,037 | 0.27% | 주식 |
| MORGAN STANLEY | $42,894,746 | 378,394 | 0.27% | 주식 |
| Swedbank AB | $42,100,431 | 371,387 | 0.26% | 주식 |
| AMERICAN CENTURY COMPANIES INC | $39,177,443 | 345,602 | 0.24% | 주식 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $38,530,157 | 339,892 | 0.24% | 주식 |
| CAPITAL FUND MANAGEMENT S.A. | $38,125,008 | 336,318 | 0.24% | 주식 |
| VANGUARD ASSET MANAGEMENT, Ltd | $37,984,782 | 335,081 | 0.23% | 주식 |
| Grantham, Mayo, Van Otterloo & Co. LLC | $36,114,682 | 318,584 | 0.22% | 주식 |
| Aware Super Pty Ltd as trustee of Aware Super | $34,779,982 | 306,810 | 0.21% | 주식 |
| Arbejdsmarkedets Tillaegspension | $33,826,624 | 298,400 | 0.21% | 주식 |
| BARCLAYS PLC | $32,329,252 | 285,191 | 0.20% | 주식 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $32,129,398 | 283,428 | 0.20% | 주식 |
| Ensign Peak Advisors, Inc | $30,602,212 | 269,956 | 0.19% | 주식 |
| Illinois Municipal Retirement Fund | $29,511,916 | 260,338 | 0.18% | 주식 |
| WINTON GROUP Ltd | $28,839,691 | 254,408 | 0.18% | 주식 |
| PFA Pension, Forsikringsaktieselskab | $28,624,373 | 252,509 | 0.18% | 주식 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $26,717,581 | 236,172 | 0.17% | 주식 |
| TODD ASSET MANAGEMENT LLC | $26,568,750 | 234,375 | 0.16% | 주식 |
| BANK OF AMERICA CORP /DE/ | $25,899,133 | 228,468 | 0.16% | 주식 |
| PRINCIPAL FINANCIAL GROUP INC | $24,961,078 | 220,193 | 0.15% | 주식 |
| Andra AP-fonden | $24,381,598 | 259,048 | 0.15% | 주식 |
| Quantinno Capital Management LP | $24,309,704 | 214,446 | 0.15% | 주식 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $24,037,194 | 212,043 | 0.15% | 주식 |
| Baird Financial Group, Inc. | $23,690,539 | 208,985 | 0.15% | 주식 |
| Eurizon Capital SGR S.p.A. | $23,250,000 | 204,785 | 0.14% | 주식 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $22,709,932 | 241,287 | 0.14% | 주식 |
| Korea Investment CORP | $22,164,827 | 195,526 | 0.14% | 주식 |
| KLP KAPITALFORVALTNING AS | $21,799,695 | 192,305 | 0.13% | 주식 |
| Catalio Capital Management, LP | $21,722,837 | 191,627 | 0.13% | 주식 |
| PRUDENTIAL FINANCIAL INC | $21,650,853 | 190,992 | 0.13% | 주식 |
| ROYAL LONDON ASSET MANAGEMENT LTD | $21,575,016 | 190,323 | 0.13% | 주식 |
| Fideuram Asset Management (Ireland) dac | $20,928,446 | 213,883 | 0.13% | 주식 |
| FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | $20,401,285 | 179,969 | 0.13% | 주식 |
| APG Asset Management N.V. | $20,193,310 | 203,661 | 0.12% | 주식 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $19,499,734 | 172,016 | 0.12% | 주식 |
| SECTOR GAMMA AS | $19,356,560 | 170,753 | 0.12% | 주식 |
| MARTINGALE ASSET MANAGEMENT L P | $19,137,209 | 168,818 | 0.12% | 주식 |
| CWM, LLC | $19,084,906 | 202,772 | 0.12% | 주식 |
| Bridgewater Associates, LP | $19,073,160 | 168,253 | 0.12% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $18,937,791 | 201,209 | 0.12% | 주식 |
| Candriam S.C.A. | $18,443,367 | 162,854 | 0.11% | 주식 |
| Focus Partners Wealth | $18,354,947 | 161,917 | 0.11% | 주식 |
| DNB Asset Management AS | $18,304,239 | 161,470 | 0.11% | 주식 |
| SEI INVESTMENTS CO | $18,019,140 | 158,955 | 0.11% | 주식 |
| Trails Edge Capital Partners, LP | $17,570,800 | 155,000 | 0.11% | 주식 |
| Jefferies Financial Group Inc. | $17,321,295 | 152,799 | 0.11% | 주식 |
| SAWGRASS ASSET MANAGEMENT LLC | $17,250,671 | 152,176 | 0.11% | 주식 |
| Mitsubishi UFJ Trust & Banking Corp | $17,215,756 | 151,868 | 0.11% | 주식 |
| AVIVA PLC | $16,882,025 | 148,924 | 0.10% | 주식 |
| Driehaus Capital Management LLC | $16,794,397 | 148,151 | 0.10% | 주식 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $16,681,037 | 147,151 | 0.10% | 주식 |
회사 내부자 61 명의 내부자 · 33 임원 · 17 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| William Meury | Chief Executive Officer | 2026년 7월 16일 A | 183,129 | 0 | 0 | $0 |
| Herve Hoppenot | Special Advisor to the CEO | 2025년 7월 15일 F | 517,146 | 0 | 0 | $0 |
| Christiana Stamoulis | EVP & Chief Financial Officer | 2025년 7월 15일 A | 125,759 | 0 | 0 | $0 |
| David W Gryska | Executive Vice President, CFO | 2018년 7월 16일 F | 10,235 | 0 | 0 | $0 |
| David C Hastings | Chief Financial Officer | 2014년 6월 5일 M | 8,500 | 0 | 0 | $0 |
| Pablo J Cagnoni | President, Global Head of R&D | 2026년 8월 19일 S | 183,200 | 0 | 7 | $-11,304,514 |
| Lee Heeson | EVP, Head of Incyte Intl | 2026년 7월 23일 A | 32,778 | 0 | 0 | $0 |
| Michael James Morrissey | EVP, Head of Tech. Operations | 2026년 7월 23일 A | 81,515 | 0 | 0 | $0 |
| Richard A. Hoffman | EVP & General Counsel | 2026년 7월 16일 A | 16,861 | 0 | 0 | $0 |
| David H Gardner | EVP, Chief Strategy Officer | 2026년 7월 16일 A | 16,824 | 0 | 0 | $0 |
| Ramitpal K Basi | EVP, Human Resources | 2026년 7월 16일 A | 11,497 | 0 | 0 | $0 |
| Mohamed Khairie Issa | EVP, Head of U.S. Commercial | 2026년 7월 16일 A | 71,797 | 0 | 1 | $-125,706 |
| Thomas Tray | Principal Accounting Officer | 2026년 7월 16일 A | 21,699 | 0 | 1 | $-263,900 |
| Steven H Stein | CMO & Head of Late-Stage Dev. | 2026년 7월 16일 A | 30,916 | 0 | 2 | $-3,407,541 |
| Sheila A. Denton | EVP & General Counsel | 2025년 8월 15일 M | 33,200 | 0 | 0 | $0 |
| Vijay K Iyengar | EVP, GMAPPS | 2025년 7월 16일 S | 40,540 | 0 | 0 | $0 |
| Barry P Flannelly | EVP & General Manager US | 2025년 7월 16일 S | 35,149 | 0 | 0 | $0 |
| Matteo Trotta | EVP, GM, Dermatology US | 2025년 7월 15일 A | 15,016 | 0 | 0 | $0 |
| Paula J Swain | EVP, Human Resources | 2025년 7월 15일 A | 106,482 | 0 | 0 | $0 |
| Jonathan Elliott Dickinson | EVP, General Manager, Europe | 2024년 9월 12일 S | 36,390 | 0 | 0 | $0 |
| Dashyant Dhanak | EVP & Chief Scientific Officer | 2023년 7월 14일 A | 58,968 | 0 | 0 | $0 |
| Maria E Pasquale | EVP & General Counsel | 2023년 7월 14일 A | 69,724 | 0 | 0 | $0 |
| Paul Trower | Principal Accounting Officer | 2022년 1월 19일 A | 32,268 | 0 | 0 | $0 |
| Yao Wenqing | EVP, Head of Discovery Chem | 2021년 7월 2일 A | 98,575 | 0 | 0 | $0 |
| Reid M Huber | EVP, Chief Scientific Officer | 2018년 7월 16일 F | 34,571 | 0 | 0 | $0 |
| Eric H. Siegel | EVP, General Counsel | 2017년 9월 13일 F | 21,053 | 0 | 0 | $0 |
| Richard S Levy | EVP, Chief Drug Dev Officer | 2016년 1월 6일 M | 16,926 | 0 | 0 | $0 |
| James M Daly | EVP, Chief Commercial Officer | 2015년 6월 23일 M | 3,521 | 0 | 0 | $0 |
| Patricia S Andrews | Chief Commercial Officer | 2012년 1월 19일 A | — | 0 | 0 | $0 |
| Patricia A Schreck | EVP, General Counsel | 2011년 5월 10일 M | 4,500 | 0 | 0 | $0 |
| Brian W Metcalf | Chief Drug Discovery Scientist | 2011년 4월 11일 M | 66,504 | 0 | 0 | $0 |
| Steven M. Friedman | EVP, Biology & Preclinical Dev | 2010년 5월 18일 A | 38,137 | 0 | 0 | $0 |
| John A Keller | Chief Business Officer | 2008년 2월 8일 A | — | 0 | 0 | $0 |
| Paul J Clancy | 이사 | 2026년 6월 30일 A | 25,635 | 0 | 1 | $-1,423,950 |
| Edmund Harrigan | 이사 | 2026년 6월 30일 A | 23,019 | 0 | 0 | $0 |
| Katherine A High | 이사 | 2026년 6월 8일 A | 14,983 | 0 | 0 | $0 |
| Jacqualyn A Fouse | 이사 | 2026년 6월 8일 A | 20,968 | 0 | 0 | $0 |
| Jean Jacques Bienaime | 이사 | 2026년 6월 8일 A | 24,424 | 0 | 0 | $0 |
| Otis W Brawley | 이사 | 2026년 6월 8일 A | 12,894 | 0 | 0 | $0 |
| Susanne Schaffert | 이사 | 2024년 6월 12일 A | 5,720 | 0 | 0 | $0 |
| Wendy L Dixon | 이사 | 2022년 3월 31일 A | 17,768 | 0 | 0 | $0 |
| Paul A Friedman, M.D. | 이사 | 2020년 5월 26일 A | 256,813 | 0 | 0 | $0 |
| Paul A Brooke | 이사 | 2020년 3월 31일 A | 221,911 | 0 | 0 | $0 |
| Barry A Ariko | 이사 | 2015년 3월 12일 M | 45,834 | 0 | 0 | $0 |
| Richard U De Schutter | 이사 | 2015년 3월 5일 M | 92,290 | 0 | 0 | $0 |
| Roy A Whitfield | 이사 | 2013년 12월 17일 M | 666,082 | 0 | 0 | $0 |
| John F Niblack | 이사 | 2011년 5월 20일 A | — | 0 | 0 | $0 |
| Fred B Craves | 이사 | 2005년 6월 1일 A | 196,793 | 0 | 0 | $0 |
| INCYTE CORP | 10% 소유주 | 2021년 1월 25일 A | 3,550,000 | 0 | 0 | $0 |
| DAMIAL FOUNDATION INC | 10% 소유주 | 2004년 2월 11일 S | — | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 7 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker, FBB2, LLC, FBB3 LLC, FBB Associates ×21 제출 서류 | 2026년 5월 11일 | 15.60% | 수정본 | 수동적 투자 | SEC |
| Incyte Corporation ×3 제출 서류 | 2023년 8월 14일 | — | 최초 제출 | 자본 구조 | SEC |
| Baker Bros. Advisors, LLC, Julian C. Baker, Felix J. Baker, FBB2, LLC, FBB Associates ×2 제출 서류 | 2012년 6월 15일 | — | 최초 제출 | — | SEC |
| Julian C. Baker, Felix J. Baker ×12 제출 서류 | 2009년 10월 1일 | — | 최초 제출 | — | SEC |
| 미공개 보고자, 미공개 보고자, 미공개 보고자, 미공개 보고자 | 2004년 2월 25일 | — | 최초 제출 | — | SEC |
| 미공개 보고자, 미공개 보고자, 미공개 보고자, 미공개 보고자, 미공개 보고자, 미공개 보고자 | 2003년 9월 29일 | — | 최초 제출 | — | SEC |
| 미공개 보고자, 미공개 보고자, 미공개 보고자, 미공개 보고자, 미공개 보고자, 미공개 보고자 | 2002년 8월 15일 | — | 최초 제출 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 214 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| BRNY · EA Series Trust | 3.64% | 211,562 NS | 2026년 4월 30일 | N-PORT |
| IDNA · iShares Trust | 3.62% | 71,574 SH | 2026년 8월 20일 | 일간 |
| PBE · Invesco Exchange-Traded Fund Trust | 2.99% | 94,349 SH | 2026년 8월 20일 | 일간 |
| UPGD · Invesco Exchange-Traded Fund Trust | 2.46% | 23,365 SH | 2026년 8월 20일 | 일간 |
| BUL · Pacer Funds Trust | 2.38% | 31,787 NS | 2026년 4월 30일 | N-PORT |
| SAWG · ETF Series Solutions | 2.36% | 624 NS | 2026년 4월 30일 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2.19% | 201,047 NS | 2026년 4월 30일 | N-PORT |
| FGSI · First Trust Exchange-Traded Fund IV | 1.98% | 623 NS | 2026년 4월 30일 | N-PORT |
| SMRI · EA Series Trust | 1.96% | 111,283 NS | 2026년 4월 30일 | N-PORT |
| SPGP · Invesco Exchange-Traded Fund Trust | 1.87% | 335,552 SH | 2026년 8월 20일 | 일간 |
| RPG · Invesco Exchange-Traded Fund Trust | 1.87% | 286,479 SH | 2026년 8월 20일 | 일간 |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1.78% | 9,967 NS | 2026년 4월 30일 | N-PORT |
| IBB · iShares Trust | 1.74% | 1,479,957 SH | 2026년 8월 20일 | 일간 |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.72% | 112,166 SH | 2026년 8월 20일 | 일간 |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 1.60% | 11,057 SH | 2026년 8월 20일 | 일간 |
| BBP · ETFis Series Trust I | 1.59% | 9,918 NS | 2026년 4월 30일 | N-PORT |
| ABOT · Abacus FCF ETF Trust | 1.59% | 736 NS | 2026년 4월 30일 | N-PORT |
| CALF · Pacer Funds Trust | 1.55% | 561,166 NS | 2026년 4월 30일 | N-PORT |
| NUMG · Nushares ETF Trust | 1.44% | 53,580 NS | 2026년 4월 30일 | N-PORT |
| AGNG · Global X Funds | 1.36% | 11,515 NS | 2026년 5월 31일 | N-PORT |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 1.24% | 115,625 SH | 2026년 8월 20일 | 일간 |
| COWG · Pacer Funds Trust | 1.21% | 275,493 NS | 2026년 4월 30일 | N-PORT |
| FLOW · Global X Funds | 1.20% | 3,543 NS | 2026년 5월 31일 | N-PORT |
| GURU · Global X Funds | 1.01% | 6,203 NS | 2026년 4월 30일 | N-PORT |
| BIB · ProShares Trust | 0.97% | 7,359 NS | 2026년 5월 31일 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.94% | 51,287 NS | 2026년 4월 30일 | N-PORT |
| TMFX · RBB Fund, Inc. | 0.94% | 3,113 NS | 2026년 5월 31일 | N-PORT |
| OASC · Unified Series Trust | 0.91% | 7,915 NS | 2026년 5월 31일 | N-PORT |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0.89% | 56,482 NS | 2026년 4월 30일 | N-PORT |
| ROE · EA Series Trust | 0.87% | 23,347 NS | 2026년 5월 29일 | N-PORT |
| SPVM · Invesco Exchange-Traded Fund Trust | 0.84% | 9,113 SH | 2026년 8월 20일 | 일간 |
| JMID · Janus Detroit Street Trust | 0.83% | 1,595 NS | 2026년 4월 30일 | N-PORT |
| JOET · Virtus ETF Trust II | 0.79% | 19,541 NS | 2026년 4월 30일 | N-PORT |
| INFO · Harbor ETF Trust | 0.75% | 61,119 NS | 2026년 4월 30일 | N-PORT |
| SDG · iShares Trust | 0.73% | 10,188 SH | 2026년 8월 20일 | 일간 |
| CLSE · Trust for Professional Managers | 0.71% | 45,326 NS | 2026년 5월 31일 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0.64% | 85,796 NS | 2026년 4월 30일 | N-PORT |
| QGRO · AMERICAN CENTURY ETF TRUST | 0.64% | 146,423 NS | 2026년 5월 31일 | N-PORT |
| ESMV · iShares Trust | 0.55% | 339 SH | 2026년 8월 20일 | 일간 |
| VBK · VANGUARD INDEX FUNDS | 0.53% | 2,249,253 SH | 2026년 8월 19일 | 일간 |
| EBI · RBB Fund Trust | 0.52% | 35,279 NS | 2026년 5월 31일 | N-PORT |
| TECB · iShares Trust | 0.50% | 19,516 SH | 2026년 8월 20일 | 일간 |
| USMV · iShares Trust | 0.48% | 908,964 SH | 2026년 8월 20일 | 일간 |
| AFMC · First Trust Exchange-Traded Fund VI… | 0.48% | 7,994 NS | 2026년 5월 31일 | N-PORT |
| VFQY · VANGUARD WELLINGTON FUND | 0.46% | 19,147 SH | 2026년 8월 19일 | 일간 |
| AFLG · First Trust Exchange-Traded Fund VI… | 0.45% | 29,860 NS | 2026년 5월 31일 | N-PORT |
| FLCV · Federated Hermes ETF Trust | 0.44% | 4,411 NS | 2026년 5월 31일 | N-PORT |
| COWZ · Pacer Funds Trust | 0.44% | 832,413 NS | 2026년 4월 30일 | N-PORT |
| QQWZ · Pacer Funds Trust | 0.43% | 2,130 NS | 2026년 4월 30일 | N-PORT |
| ACWV · iShares, Inc. | 0.42% | 111,137 SH | 2026년 8월 20일 | 일간 |